DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears.

MLA

Bollmann, R., et al. “DNA Cytometry Confirms the Utility of the Bethesda System for the Classification of Papanicolaou Smears.” Cancer, vol. 93, no. 3, June 2001, pp. 222–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11391611&authtype=sso&custid=ns315887.

APA

Bollmann, R., Bollmann, M., Henson, D. E., & Bodo, M. (2001). DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears. Cancer, 93(3), 222–228.

Chicago

Bollmann, R, M Bollmann, D E Henson, and M Bodo. 2001. “DNA Cytometry Confirms the Utility of the Bethesda System for the Classification of Papanicolaou Smears.” Cancer 93 (3): 222–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11391611&authtype=sso&custid=ns315887.